PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial

Completed · Phase 4 · Has a placebo group

Conditions studied: Portopulmonary Hypertension

In brief

24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.

Key facts

Study ID
NCT02382016
Run by
Actelion
People needed
85
Starts
2015-06-23
Expected to finish
2018-10-31
Last updated by the study team
2025-03-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.